Acorda Therapeutics Company
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Investors
%20.jpg)
Headquarters:
United States
Funding Status:
IPO
Employee Number:
251-500
Estimated Revenue:
$50M to $100M
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Immunotherapy
Investor Type:
Company
Founded Date:
1995
Industry:
Loss of Proteostasis